Most Americans Don't Know Alcohol's Links to Cancer
By Carole Tanzer Miller HealthDay Reporter
FRIDAY, Nov. 29, 2024 — Less than half of Americans realize that they're increasing their risk of cancer with every beer, cocktail or shot of whiskey.
Despite public health warnings about the links between drinking and cancer risk, this widespread lack of awareness is the key takeaway from a new nationwide survey.
"Public health messages about the risks associated with drinking alcohol have to overcome the effects of decades of sophisticated marketing and positive media portrayals," said Patrick Jamieson, director of of the Annenberg Public Policy Center, which conducted the poll.
More than half of adults in the U.S. drink alcohol — 17% binge drink and and 6% are heavy drinkers, according to the U.S. Centers for Disease Control and Prevention. Binge drinking is four or more drinks in two hours for women and five or more for men.
The CDC says people can "lower your risk for cancer by drinking less alcohol or drinking none at all."
But that message has apparently been lost on most Americans.
Six in 10 surveyed were unaware that regular alcohol use increases odds for developing cancer, the survey showed.
Four in 10 weren't certain that statement was true, and 2 in 10 were even farther off the mark — either wrongly saying drinking would have no effect or would lower a person's cancer risk, the survey found.
Respondents came from a panel of 1,744 adults questioned in September.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-30 00:00
Read more
- 2010 to 2021 Saw Rise in Postpartum Depression
- AI Helps Spot Brain Tumor Tissue Surgeons Miss
- Arrowhead Pharmaceuticals Submits New Drug Application to U.S. FDA for Plozasiran for the Treatment of Familial Chylomicronemia Syndrome
- Leads Biolabs Receives Orphan Drug Designation from the US FDA for LBL-034, a Uniquely Designed, Highly Differentiated Anti-GPRC5D/CD3 Bispecific Antibody, for the Treatment of Multiple Myeloma
- Syndax Announces Positive Pivotal Topline Results from Relapsed or Refractory mNPM1 AML Cohort in AUGMENT-101 Trial of Revumenib
- AHA: Intensive Strategy for Lowering Systolic BP Beneficial in Type 2 Diabetes
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions